Physician

Jenny Mccallister Riley, M.D.

According to 2025 Medicare claims, Jenny Riley, M.D. (NPI: 1043504020) practices hematology/oncology in the Charleston-North Charleston, SC market, with the plurality of this provider's patient population coming from Charleston, SC. This provider's primary affiliated billing organization is LOWCOUNTRY ONCOLOGY ASSOCIATES, LLC (NPI: 1427809664; TIN: 991177652) and primary practice location at 29464-3204. Riley is affiliated with the Hampton Roads Good Help ACO (ACO ID: A3324), participating under the MSSP model.

Riley's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 577 traditional Medicare patients, billed 25,176 HCPCS/CPT codes, and received $579,765 in Medicare payments. The top billing code was 99204 (New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more). Part D data shows 1,467 prescription claims across 263 beneficiaries totaling $1,836,686 in drug costs, led by Lenalidomide (Lenalidomide). DME data shows 52 claims. Open Payments data shows 116 records totaling $2,578. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has fallen sharply in recent years, from $4,523 to $579,765. In contrast, Part D prescription costs have risen steadily, from $15,823 to $1,836,686. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	42	88	$4,523
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	260	27,651	$252,179
2019	512	125,140	$1,225,444
2020	663	138,166	$1,694,035
2021	567	104,284	$1,625,952
2022	583	125,886	$1,793,076
2023	532	1,504	$134,080
2024	577	25,176	$579,765

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	45	152	$15,823
2016	30	101	$93,437
2017	31	81	$64,388
2018	62	188	$62,183
2019	157	1,098	$785,242
2020	225	1,417	$1,570,506
2021	233	1,319	$2,021,832
2022	242	1,417	$2,356,469
2023	255	1,441	$1,960,024
2024	263	1,467	$1,836,686

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	16	$1,744
2021	N/R	16	$1,548
2022	N/R	N/R	N/R
2023	N/R	26	$5,678
2024	N/R	52	$1,690

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99204	New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more	83	83	$105
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	292	801	$87
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	315	420	$59
36415	Insertion of needle into vein for collection of blood sample	199	299	$9
85025	Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count	195	303	$8

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Lenalidomide	Lenalidomide	32	791	$409,004
Ibrance	Palbociclib	22	616	$328,053
Calquence	Acalabrutinib Maleate	14	420	$210,816
Xarelto	Rivaroxaban	67	3,449	$62,038
Eliquis	Apixaban	71	2,910	$54,044

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
J8521	Capecitabine, oral, 500 mg	N	N/R	19	$755
E0657	Segmental pneumatic appliance for use with pneumatic compressor, chest	Y	N/R	14	$697
Q0512	Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for a subsequent prescription in a 30-day period	N	N/R	19	$238

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	116	$2,578	Novartis Pharmaceuticals Corporation
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Jenny Mccallister Riley, M.D.?

Tedicare shows public-source Medicare data for Jenny Mccallister Riley, M.D. (NPI 1043504020), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Jenny Mccallister Riley, M.D. have ACO affiliation data?

Jenny Mccallister Riley, M.D. is shown with ACO affiliation data for Hampton Roads Good Help ACO (MSSP, ACO ID A3324).

What billing organization is linked to Jenny Mccallister Riley, M.D.?

Jenny Mccallister Riley, M.D. is linked to LOWCOUNTRY ONCOLOGY ASSOCIATES, LLC (billing NPI 1427809664) in the available physician profile data.

Does Jenny Mccallister Riley, M.D. have Open Payments data?

Jenny Mccallister Riley, M.D. has 116 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.